CYP cynata therapeutics limited

it’s a good question to ask I agree. But I would imagine that...

  1. 308 Posts.
    lightbulb Created with Sketch. 248
    it’s a good question to ask I agree. But I would imagine that even if IPSC MSCs also used 3D scaffolding technology, it would still put the batch quantities and quality vastly ahead of bone marrow derived technologies also using 3D scaffolding due to the same issue of batch to batch variability and senescence?
    perhaps we can ask Killian for an answer to this.As Killian knows both techs more than most
    Last edited by ZolRab: 29/07/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.0¢
Change
0.000(0.00%)
Mkt cap ! $36.15M
Open High Low Value Volume
16.0¢ 16.0¢ 16.0¢ $1.021K 6.379K

Buyers (Bids)

No. Vol. Price($)
4 77738 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 3400 1
View Market Depth
Last trade - 09.59am 24/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.